(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
Digital health company Hims & Hers has hit a milestone many in the industry have been working toward.
On Monday, Hims posted its first-ever net income for Q4 2023 of $1.2 million, compared with a net loss of $10.9 million in the fourth quarter of 2022. The company, which prescribes and ships medications for conditions like hair loss and dermatology to consumers and doesn’t take insurance, is one of the few of a generation of startups that has reached that goal after years of trying.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.